PMC:7326463 / 2759-2964
Annnotations
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22 | 26-33 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T8 | 160-172 | Chemical | denotes | voriconazole | http://purl.obolibrary.org/obo/CHEBI_10023 |
T9 | 174-186 | Chemical | denotes | posaconazole | http://purl.obolibrary.org/obo/CHEBI_64355 |
T10 | 191-204 | Chemical | denotes | isavuconazole | http://purl.obolibrary.org/obo/CHEBI_85979 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
109 | 160-172 | Chemical | denotes | voriconazole | MESH:D065819 |
110 | 174-186 | Chemical | denotes | posaconazole | MESH:C101425 |
111 | 191-204 | Chemical | denotes | isavuconazole | MESH:C508735 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22 | 0-205 | Sentence | denotes | Antifungal susceptibility testing determined using the gradient concentration strips method showed high minimal inhibitory concentrations (MICs) (>32 mg/L) for voriconazole, posaconazole and isavuconazole. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T40 | 160-172 | CHEBI:10023;CHEBI:10023 | denotes | voriconazole |
T41 | 174-186 | CHEBI:64355;CHEBI:64355 | denotes | posaconazole |
T42 | 191-204 | CHEBI:85979;CHEBI:85979 | denotes | isavuconazole |
T7769 | 160-172 | CHEBI:10023;CHEBI:10023 | denotes | voriconazole |
T37012 | 174-186 | CHEBI:64355;CHEBI:64355 | denotes | posaconazole |
T51161 | 191-204 | CHEBI:85979;CHEBI:85979 | denotes | isavuconazole |